These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25185737)

  • 1. Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply.
    Kimer N; Krag A; Gluud LL
    Aliment Pharmacol Ther; 2014 Oct; 40(7):858-9. PubMed ID: 25185737
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: the effects of rifaximin in hepatic encephalopathy.
    Dai C; Jiang M; Sun MJ
    Aliment Pharmacol Ther; 2014 Oct; 40(7):857-8. PubMed ID: 25185736
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy.
    Kimer N; Krag A; Møller S; Bendtsen F; Gluud LL
    Aliment Pharmacol Ther; 2014 Jul; 40(2):123-32. PubMed ID: 24849268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rifaximin for hepatic encephalopathy in children. Case report].
    Malla I; Torres Cerino V; Villa A; Cheang Y; Giacove G; Pedreira A; Silva M
    Arch Argent Pediatr; 2011 Dec; 109(6):e113-5. PubMed ID: 22231877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of rifaximin in the treatment of hepatic encephalopathy].
    Sanchez-Delgado J; Miquel M
    Gastroenterol Hepatol; 2016 Apr; 39(4):282-92. PubMed ID: 26545947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin may have a dramatic effect on hepatic encephalopathy.
    Lamb C; Reddy AV
    Clin Med (Lond); 2012 Oct; 12(5):489-90. PubMed ID: 23101155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.
    Jiang Q; Jiang XH; Zheng MH; Jiang LM; Chen YP; Wang L
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1064-70. PubMed ID: 19047837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin: an alternative for the treatment of hepatic encephalopathy.
    Rigali VT
    Conn Med; 2006 Sep; 70(8):499-501. PubMed ID: 17089807
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: prolonged remission from hepatic encephalopathy with rifaximin.
    Orr JG; Hudson M
    Aliment Pharmacol Ther; 2015 Jan; 41(2):228. PubMed ID: 25511766
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.
    Williams R; Bass N
    Rev Gastroenterol Disord; 2005; 5 Suppl 1():S10-8. PubMed ID: 15976747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifaximin therapy in minimal hepatic encephalopathy cirrhotics.
    Zullo A; Hassan C; Lorenzetti R
    Am J Gastroenterol; 2011 Nov; 106(11):2041; author reply 2041-2. PubMed ID: 22056578
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifaximin and nonabsorbable disaccharides for hepatic encephalopathy.
    Guslandi M; Cella A
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):376. PubMed ID: 20134260
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifaximin for the treatment of hepatic encephalopathy.
    Lawrence KR; Klee JA
    Pharmacotherapy; 2008 Aug; 28(8):1019-32. PubMed ID: 18657018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifaximin (Xifaxan 550) for hepatic encephalopathy.
    Med Lett Drugs Ther; 2010 Nov; 52(1350):87. PubMed ID: 21045761
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy.
    Kowdley KV; Burman BE
    Ann Intern Med; 2013 Oct; 159(8):JC8. PubMed ID: 24126669
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remain.
    Congly SE; Leise MD
    Am J Gastroenterol; 2014 Apr; 109(4):598. PubMed ID: 24698864
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifaximin for the treatment of hepatic encephalopathy.
    Mantry PS; Munsaf S
    Transplant Proc; 2010 Dec; 42(10):4543-7. PubMed ID: 21168733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
    Ahire K; Sonawale A
    J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.
    Huang E; Esrailian E; Spiegel BM
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1147-61. PubMed ID: 17894657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
    MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.